Trials / Completed
CompletedNCT05538767
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Trichuris Trichiura and Hookworm: Randomized Two Stages Phase II Seamless Adaptive Controlled Single-blind Trials
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 320 (actual)
- Sponsor
- Jennifer Keiser · Academic / Other
- Sex
- All
- Age
- 12 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To compare the efficacy and safety of emodepside to that of albendazole (Zentel®) in participants aged 12-60, inclusive, infected with hookworm.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Emodepside | Treatment with Emodepside 30 mg |
| DRUG | Albendazole 400mg | Treatment with Albendazole 400 mg |
Timeline
- Start date
- 2022-09-16
- Primary completion
- 2023-04-11
- Completion
- 2023-04-11
- First posted
- 2022-09-14
- Last updated
- 2023-06-15
Locations
1 site across 1 country: Tanzania
Source: ClinicalTrials.gov record NCT05538767. Inclusion in this directory is not an endorsement.